Dasatinib suppresses in vitro natural killer cell cytotoxicity

Blood

Volumn 111, Issue 8, 2008, Pages 4415-4416

  Blake, Stephen J ^a   Lyons, A Bruce ^a   Fraser, Cara K ^a   Hayball, John D ^a   Hughes, Timothy P ^a  

^a INSTITUTE OF MEDICAL AND VETERINARY SCIENCE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOXYFLUORESCEIN DIACETATE SUCCINIMIDYL ESTER; DASATINIB; PROTEIN KINASE FYN; PROTEIN KINASE LCK; PROTEIN TYROSINE KINASE; T LYMPHOCYTE RECEPTOR; LYMPHOCYTE ANTIGEN RECEPTOR; PROTEIN KINASE INHIBITOR; PYRIMIDINE DERIVATIVE; THIAZOLE DERIVATIVE;

CELL FUNCTION; CENTRIFUGATION; CHRONIC MYELOID LEUKEMIA; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOTOXICITY; ENZYME ACTIVATION; ENZYME INHIBITION; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNOMAGNETIC SEPARATION; IN VITRO STUDY; LETTER; NATURAL KILLER CELL; PERIPHERAL BLOOD STEM CELL; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; TARGET CELL; CELL STRAIN K 562; CYTOLOGY; DRUG ANTAGONISM; DRUG EFFECT; LEUKEMIA CELL LINE; METABOLISM; NOTE;

CYTOTOXICITY, IMMUNOLOGIC; HUMANS; JURKAT CELLS; K562 CELLS; KILLER CELLS, NATURAL; LEUKEMIA, MYELOGENOUS, CHRONIC, BCR-ABL POSITIVE; PROTEIN KINASE INHIBITORS; PYRIMIDINES; RECEPTORS, ANTIGEN, T-CELL; SIGNAL TRANSDUCTION; SRC-FAMILY KINASES; THIAZOLES;

EID: 43249096013     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2008-02-138701     Document Type: Letter

References (9)

1. Schade AE, Schieven GL, Townsend R, et al. Dasatinib, a small molecule protein tyrosine kinase inhibitor, inhibits T cell activation and proliferation. Blood. 2008;111:1366-1377.
2. Hochhaus A, Kantarjian HM, Baccarani M. et al. Dasatinib induces notable hematologic and cytogenetic responses in chronic-phase chronic myeloid leukemia after failure of imatinib therapy. Blood. 2007; 109:2303-2309.
3. Höppner M, Luhm J, Schlenke P, Koritke P, Frohn C. A flow-cytometry based cytotoxicity assay using stained effector cells in combination with native target cells. J Immunol Methods. 2002;267:157-163.
4. Lyons AB. Parish CR. Determination of lymphocyte division by flow cytometry. J Immunol Methods. 1994;171:131-137.
5. Vivier E. Nunes JA, Vely F. Natural killer cell signaling pathways. Science. 2004;306:1517-1519.
6. Lowin-Kropf B, Kunz B. Schneider P, Held W. A role for the src family kinase Fyn in NK cell activation and the formation of the repertoire of Ly49 receptors. Eur J Immunol. 2002;32:773-782.
7. Pignata C, Prasad KV; Robertson MJ, Levine H, Rudd CE, Ritz J. Fc gamma RIIIA-mediated signaling involves src-family Ick in human natural killer cells. J Immunol. 1993:151:6794-6800.
8. Tabiasco J, Espinosa E, Hudrisier D, Joly E, Fournie JJ, Vercellone A. Active trans-synaptic capture of membrane fragments by natural killer cells. Eur J Immunol. 2002;32:1502-1508.
9. Shah NP, Tran C, Lee FY, Chen P, Norris D. Sawyers CL. Overriding imatinib resistance with a novel ABL kinase inhibitor. Science. 2004;305:399-401.